Northland Securities analyst Michael Grondahl reaffirmed his buy rating for Abacus Life, Inc. (NASDAQ: ABL) on December 5, according to TheFly. The analyst kept the stock’s price target at $13.50.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback